Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. (2018)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-018-03215-x
PubMed Identifier: 29497091
Publication URI: http://europepmc.org/abstract/MED/29497091
Type: Journal Article/Review
Volume: 9
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723